<DOC>
	<DOCNO>NCT01218126</DOCNO>
	<brief_summary>Randomised , double-blind , parallel-group , multi-centre study evaluate three dos losmapimod ( 2.5mg , 7.5 mg 15 mg ) twice daily ( BID ) versus placebo exercise tolerance . Eligible subject randomise treatment one-week run-in period . The duration treatment period 24 week . An estimated 1000 subject screen reach target enrolment approximately 600 randomised subject .</brief_summary>
	<brief_title>Randomised , Double-Blind , Placebo-Controlled , Parallel-Group , Multi-centre , Dose Ranging Study Evaluate Efficacy Safety Losmapimod Tablets Administered Twice Daily Compared With Placebo 24 Weeks Adult Subjects With Chronic Obstructive Pulmonary Disease ( COPD ) .</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>clinical history COPD accordance definition American Thoracic Society/European Respiratory Society FEV1/FVC ratio ≤0.70 FEV1 ≤ 80 % predict normal 6MWD &lt; 350m male female outpatient age ≥40 year age current prior history ≥10 packyears cigarette smoke aspartate transaminase ( AST ) alanine transaminase ( ALT ) &lt; 2x Upper Limit Normal ( ULN ) alkaline phosphatase ( alk phos ) , bilirubin &lt; 1.5xULN ( isolated bilirubin &gt; 1.5xULN acceptable bilirubin fractionate direct bilirubin &lt; 35 % ) QTc &lt; 450 msec* baseline ECG . For subject baseline complete bundle branch block , QTc must &lt; 480msec* baseline ECG . current diagnosis asthma pregnant lactate α1antitrypsin deficiency lung resection chest Xray ( CT scan ) reveals evidence clinically significant abnormality believe due presence COPD exacerbation COPD within previous 12 week treatment roflumilast within previous 2 week throughout treatment period lower respiratory tract infection require use antibiotic within previous 12 week longterm oxygen therapy ( LTOT ) nocturnal oxygen therapy require great 12 hour day participation acute phase Pulmonary Rehabilitation Program within 12 week plan study carcinoma complete remission least 5 year current chronic history liver disease positive Hepatitis B surface antigen positive Hepatitis C antibody Body Mass Index ( BMI ) &gt; 35 know suspected history alcohol drug abuse within last 2 year</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>